Skip to main content

Advertisement

ADVERTISEMENT

Volume 20 - Issue 8 - August, 2008

11/24/2008
Jeffrey J. Popma, MD Author Affiliations: From Caritas St. Elizabeth Medical Center, Brighton, Massachusetts. Disclosures: Dr. Popma discloses that he has received speaker honoraria and consulting fees from Boston Scientific Corp., Bristol-Meyers Squibb, Cordis Corporation. Medtronic, Inc., Pfizer, Inc., and Sanofi-Aventis. Dr. Popma has also received research grants from Abbott Vascular, Boston Scientific Corp., Cordis Corp., ev3, Inc., and Medtronic, Inc. Address for correspondence: Jeffrey J. Popma, MD, Director, Cardiac Catheterization Laboratory, Caritas St. Elizabeth Medical Center, 736 Cambridge Street, Brighton, MA 02135. E-mail: Jeffrey.popma@caritaschristi.org
Jeffrey J. Popma, MD Author Affiliat...
The AngioJet device has been shown to be a safe and effective device for mechanical thrombectomy, yet its association with severe bradyarrhythmia has impeded its broad acceptance and widespread use. This “brady effect” has forced physicians...
The AngioJet device has been shown to be a safe and effective device for mechanical thrombectomy, yet its association with severe bradyarrhythmia has impeded its broad acceptance and widespread use. This “brady effect” has forced physicians...
The AngioJet device has been...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
David Antoniucci, MD Author Affiliations: From the Division of Cardiology, Careggi Hospital, Florence, Italy. The author reports no conflicts of interest regarding the content herein. Address for correspondence: David Antoniucci, MD, Careggi Hospital, Viale Morgagni, Florence, I-50134, Italy. E-mail: david.antoniucci@virgilio.it
David Antoniucci, MD Author Affiliat...
How to Minimize the Need for Temporary Pacemaker during Rheolytic Thrombectomy ABSTRACT: Background. Whatever the mechanism or mechanisms involved in the genesis of bradyarrhythmias during rheolytic thrombectomy (RT), the severity and...
How to Minimize the Need for Temporary Pacemaker during Rheolytic Thrombectomy ABSTRACT: Background. Whatever the mechanism or mechanisms involved in the genesis of bradyarrhythmias during rheolytic thrombectomy (RT), the severity and...
How to Minimize the Need for...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Tariqshah Syed, MD, Jacqueline Tamis-Holland, MD, David Coven, MD, PhD, Mun K. Hong, MD Author Affiliations: The authors report no conflicts of interest regarding the content herein. From the Cardiac Catheterization Laboratory and Interventional Cardiology, St. Luke’s-Roosevelt Hospital Center, New York, New York. Address for correspondence: Mun K. Hong, MD, FACC, FSCAI, Director, Cardiac Catheterization Laboratory and Interventional Cardiology, St. Luke’s-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, NY 10025. E-mail: mkhong@chpnet.org
Tariqshah Syed, MD, Jacqueline Tamis-...
In Patients at High Risk for Symptomatic Bradycardia Undergoing AngioJet Mechanical Thrombectomy? ABSTRACT: We studied the feasibility and efficacy of glycopyrrolate, a synthetic anticholinergic agent with shorter half-life and without...
In Patients at High Risk for Symptomatic Bradycardia Undergoing AngioJet Mechanical Thrombectomy? ABSTRACT: We studied the feasibility and efficacy of glycopyrrolate, a synthetic anticholinergic agent with shorter half-life and without...
In Patients at High Risk for...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Bilal Murad, MD Author Affiliations: From the North Heart Center Cardiovascular Consultants, Minneapolis, Minnesota. Disclosure: Dr. Murad discloses that he has received the following from Possis Medical, Inc.: speaker honoraria and funding to conduct the animal studies. No funding was received from Possis Medical for the human studie, and Possis was not involved in the preparation of this manuscript. Address for correspondence: Bilal Murad, MD, North Heart Center Cardiovascular Consultants, 3300 Oakdale Avenue North, Suite 200, Minneapolis, MN 55422. E-mail: mbilalmurad@gmail.com
Bilal Murad, MD Author Affiliations:...
ABSTRACT: Thrombectomy with the AngioJet® rheolytic thrombectomy catheter frequently causes bradyarrhythmias. This necessitates temporary pacemaker insertion and limits the device’s use. Novel approaches for treatment of bradyarrhythmias are...
ABSTRACT: Thrombectomy with the AngioJet® rheolytic thrombectomy catheter frequently causes bradyarrhythmias. This necessitates temporary pacemaker insertion and limits the device’s use. Novel approaches for treatment of bradyarrhythmias are...
ABSTRACT: Thrombectomy with the...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Augustin DeLago, MD Mohammad El-Hajjar, MD Mikhail Kirnus, MD Author Affiliations: From Albany Medical Center, Albany, New York. The author reports no conflicts of interest regarding the content herein. Address for correspondence: Augustin DeLago, MD, FACC, Albany Medical Center, Department of Cardiology, 43 New Scotland Avenue, Room C-716, MC15, Albany, NY 12208. E-mail: delagoa@mail.amc.edu
Augustin DeLago, MD Mohammad El-Hajja...
ABSTRACT: In patients with acute ST elevation myocardial infarction or in those with thrombus-containing lesions, percutaneous coronary intervention (PCI) represents a clinical challenge to the interventionist, because coronary thrombus is a...
ABSTRACT: In patients with acute ST elevation myocardial infarction or in those with thrombus-containing lesions, percutaneous coronary intervention (PCI) represents a clinical challenge to the interventionist, because coronary thrombus is a...
ABSTRACT: In patients with acute...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Timothy A. Mixon, MD, Gregory J. Dehmer, MD, Raul A. Santos, MD, D. Scott Gantt, DO, Mark E. Lawrence, DO, Linley E. Watson, MD Author Affiliations: From the Texas A&M Health Science Center, Scott & White Clinic, Division of Cardiology, Temple, Texas. Disclosure: Dr. Mixon discloses that he has received speaker honoraria from Possis Medical, Inc. The other authors report no conflicts of interest regarding the content herein. Address for correspondence: Timothy A. Mixon, MD, FACC, FSCAI, Assistant Professor of Medicine, Texas A&M Health Science Center, Scott & White Clinic, Division of Cardiology, 2401 S. 31st Street, Temple, TX 76504. E-mail: tmixon@swmail.sw.org
Timothy A. Mixon, MD, Gregory J. Dehm...
Induced by Rheolytic Thrombectomy and Precludes the Need for Transvenous Pacing: The Scott & White Experience ABSTRACT: Rheolytic thrombectomy (RT) is useful in certain percutaneous coronary interventions but may be associated with transient...
Induced by Rheolytic Thrombectomy and Precludes the Need for Transvenous Pacing: The Scott & White Experience ABSTRACT: Rheolytic thrombectomy (RT) is useful in certain percutaneous coronary interventions but may be associated with transient...
Induced by Rheolytic...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Dennis W.X. Zhu, MD Author Affiliations: Disclosure: Dr. Zhu has received speaker honoraria from Possis Medical, Inc. From Regions Hospital Heart Center, Saint Paul, Minnesota. Address for correspondence: Dennis W.X. Zhu, MD, FACC, Regions Hospital Heart Center, 640 Jackson Street, Saint Paul, MN 55001. E-mail: dennis.w.zhu@healthpartners.com
Dennis W.X. Zhu, MD Author Affiliati...
ABSTRACT: The AngioJet® Rheolytic™ Thrombectomy System (Possis Medical, Inc., Minneapolis, Minnesota) is an effective thrombectomy device, but it may cause bradycardias ranging from mild bradycardia to asystole and hypotension in some...
ABSTRACT: The AngioJet® Rheolytic™ Thrombectomy System (Possis Medical, Inc., Minneapolis, Minnesota) is an effective thrombectomy device, but it may cause bradycardias ranging from mild bradycardia to asystole and hypotension in some...
ABSTRACT: The AngioJet®...
11/24/2008
Journal of Invasive Cardiology
11/24/2008
Jeffrey J. Popma, MD Author Affiliations: From Caritas St. Elizabeth Medical Center, Brighton, Massachusetts. Disclosures: Dr. Popma discloses that he has received speaker honoraria and consulting fees from Boston Scientific Corp., Bristol-Meyers Squibb, Cordis Corporation. Medtronic, Inc., Pfizer, Inc., and Sanofi-Aventis. Dr. Popma has also received research grants from Abbott Vascular, Boston Scientific Corp., Cordis Corp., ev3, Inc., and Medtronic, Inc. This special supplement was made possible through a grant from Possis Medical, Inc. Address for correspondence: Jeffrey J. Popma, MD, Director, Cardiac Catheterization Laboratory, Caritas St. Elizabeth Medical Center, 736 Cambridge Street, Brighton, MA 02135. E-mail: Jeffrey.popma@caritaschristi.org
Jeffrey J. Popma, MD Author Affiliat...
Primary percutaneous coronary intervention (PCI) is the preferred treatment for revascularizing infarct-related arteries in patients experiencing acute myocardial infarction (AMI). Thrombolytic occlusion of the coronary artery is the inciting...
Primary percutaneous coronary intervention (PCI) is the preferred treatment for revascularizing infarct-related arteries in patients experiencing acute myocardial infarction (AMI). Thrombolytic occlusion of the coronary artery is the inciting...
Primary percutaneous coronary...
11/24/2008
Journal of Invasive Cardiology

Feature

Case Report
10/28/2008
Shailendra Upadhyay, MD and *Asad Sawar, MD
Shailendra Upadhyay, MD and *Asad Saw...
Author Affiliations: From the Long Island Jewish Medical Center/Schneider Children’s Hospital, New Hyde Park, New York, and the *Bradenton Heart Center, Bradenton, Florida. The authors report no conflicts of interest regarding the content...
Author Affiliations: From the Long Island Jewish Medical Center/Schneider Children’s Hospital, New Hyde Park, New York, and the *Bradenton Heart Center, Bradenton, Florida. The authors report no conflicts of interest regarding the content...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology
Case Report
10/28/2008
Yoshitaka Shiratori, MD, Yuji Oikawa, MD, Junji Yajima, MD
Yoshitaka Shiratori, MD, Yuji Oikawa,...
Author Affiliations: From the Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 8, 2007, provisional acceptance...
Author Affiliations: From the Department of Cardiology, The Cardiovascular Institute, Tokyo, Japan. The authors report no conflicts of interest regarding the content herein. Manuscript submitted November 8, 2007, provisional acceptance...
Author Affiliations: From the...
10/28/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement